Jyong Biotech Ltd. has appointed Wei (Vivi) Zhang as its new Chief Financial Officer, effective February 6, 2026. Zhang replaces Alfred Ying in the role. She brings extensive experience in finance, having previously served as CFO and director at Global Mofy AI Limited and as a consultant for a private company’s initial public offering.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jyong Biotech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013306), on February 06, 2026, and is solely responsible for the information contained therein.
Comments